RCM Stock - R1 RCM Inc.
Unlock GoAI Insights for RCM
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $2.25B | $1.81B | $1.47B | $1.27B | $1.19B |
| Gross Profit | $484.50M | $361.30M | $311.80M | $249.70M | $198.30M |
| Gross Margin | 21.5% | 20.0% | 21.1% | 19.6% | 16.7% |
| Operating Income | $147.90M | $3.00M | $145.70M | $80.00M | $112.70M |
| Net Income | $3.30M | $-57,600,000 | $87.30M | $115.20M | $12.00M |
| Net Margin | 0.1% | -3.2% | 5.9% | 9.1% | 1.0% |
| EPS | $0.01 | $-0.16 | $0.33 | $1.00 | $0.11 |
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| August 8th 2024 | Morgan Stanley | Downgrade | Equal Weight | - |
| August 1st 2024 | Stephens | Downgrade | Equal Weight | - |
| August 1st 2024 | Leerink Partners | Downgrade | Market Perform | - |
| August 1st 2024 | Jefferies | Downgrade | Hold | - |
| April 10th 2024 | KeyBanc Capital Markets | Downgrade | Sector Weight | - |
| March 20th 2024 | Citigroup | Upgrade | Buy | $16 |
| February 26th 2024 | Leerink Partners | Initiation | Outperform | $14 |
| January 3rd 2024 | Barclays | Initiation | Overweight | $14 |
| December 15th 2023 | Morgan Stanley | Upgrade | Overweight | $17← $17.5 |
| December 13th 2023 | JP Morgan | Downgrade | Neutral | $11← $20 |
| October 19th 2023 | Truist | Upgrade | Buy | $18 |
| September 22nd 2023 | Citigroup | Initiation | Buy | $20 |
| August 15th 2023 | Cantor Fitzgerald | Initiation | Overweight | $20 |
| April 12th 2023 | Stephens | Initiation | Overweight | $18 |
| April 11th 2023 | Robert W. Baird | Initiation | Outperform | $18 |
Earnings History & Surprises
RCMEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Nov 5, 2024 | $-0.15 | $-0.05 | +66.7% | ✓ BEAT |
Q3 2024 | Aug 7, 2024 | $-0.05 | $-0.02 | +60.0% | ✓ BEAT |
Q2 2024 | May 8, 2024 | $-0.05 | $-0.08 | -60.0% | ✗ MISS |
Q1 2024 | Feb 27, 2024 | — | $0.00 | — | — |
Q4 2023 | Nov 2, 2023 | — | $0.00 | — | — |
Q3 2023 | Aug 2, 2023 | $0.00 | $0.00 | +100.0% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $0.00 | $0.00 | +100.0% | ✓ BEAT |
Q1 2023 | Feb 16, 2023 | $-0.05 | $-0.09 | -76.1% | ✗ MISS |
Q4 2022 | Nov 8, 2022 | $0.11 | $-0.07 | -163.6% | ✗ MISS |
Q3 2022 | Aug 3, 2022 | $-0.07 | $0.13 | +281.5% | ✓ BEAT |
Q2 2022 | May 9, 2022 | $0.10 | $0.09 | -10.0% | ✗ MISS |
Q1 2022 | Feb 17, 2022 | $0.11 | $0.11 | 0.0% | = MET |
Q4 2021 | Nov 2, 2021 | $0.09 | $0.05 | -44.4% | ✗ MISS |
Q3 2021 | Aug 3, 2021 | $0.07 | $0.06 | -14.3% | ✗ MISS |
Q2 2021 | May 4, 2021 | $-0.09 | $-2.37 | -2533.3% | ✗ MISS |
Q1 2021 | Feb 18, 2021 | $0.06 | $0.06 | 0.0% | = MET |
Q4 2020 | Nov 3, 2020 | — | $0.04 | — | — |
Q3 2020 | Aug 4, 2020 | $0.04 | $0.03 | -14.3% | ✗ MISS |
Q2 2020 | May 5, 2020 | $0.06 | $0.05 | -16.7% | ✗ MISS |
Q1 2020 | Feb 20, 2020 | $0.04 | $0.01 | -75.0% | ✗ MISS |
Latest News
Frequently Asked Questions about RCM
What is RCM's current stock price?
What is the analyst price target for RCM?
What sector is R1 RCM Inc. in?
What is RCM's market cap?
Does RCM pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to RCM for comparison